SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

Legal marijuana shortages persist in Canada

• Legal cannabis shortages were still a problem in Canada in early 2019, several months after the country began recreational sales to adults, says a report this morning by broker Cowen
• Survey of five provinces’ online weed availability in January shows that nearly half of all items remained out-of-stock on marijuana e-commerce sites

From Bill Alpert: Legal cannabis shortages were still a problem in Canada in early 2019, several months after the country began recreational sales to adults, says a report this morning by broker Cowen. A survey of five provinces’ online weed availability in January shows that nearly half of all items remained out-of-stock on marijuana e-commerce sites. But in the relatively-populous Ontario, supplies were better, with 61% of listed products actually in-stock. In New Brunswick and Newfoundland & Labrador, however, out-of-stock rates increased.

“While it is difficult to assess how much of the change is demand versus supply driven,” wrote analyst Vivien Azer, in the note, “our view is that demand remains strong with an improving supply chain.” Cowen surveyed online shops in Ontario, British Columbia, Alberta, New Brunswick and Newfoundland & Labrador.

Among Canada’s large producers, Canopy Growth (ticker: CGC) had the largest share of in-stock product on e-commerce shelves, with a 21% share in Ontario, while Aurora Cannabis (ACB) had 12% of that province’s online market. Tilray(TLRY) and Cronos Group (CRON) each had 4%.

After a month when Canada’s pot stocks mostly wandered sideways, Canopy is flat this morning, at $44.44, while Aurora is up 9% to $9.37. Tilray is up 3%, to $69, while Cronos has jumped 6.3% to $20.21, a day before it reports December-quarter results.

Dry flower marijuana made up about three-fourths of all products at Canada’s online shops, noted Cowen, with the remaining offerings consisting of capsules, oils, and pre-roll smokes.

“We continue to believe that the category will look very different in late 2019,” the analyst wrote, “when vapor, beverages, edibles, and other form factors become available.”

Prices for dry flower held firm in January, according to Cowen, at $10.22 Canadian dollars per gram (or US$7.56). Pre-roll product commands a price premium, for its convenience, but Canadian consumers had cause to celebrate, as pre-roll’s average price fell 4% from December, to C$12.88 a gram.

Source: https://etfdailynews.com/2019/03/25/legal-marijuana-shortages-persist-in-canada/

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

CBD is booming. But US farmers struggle to keep up with demand for industrial hemp

• Retail sales of cannabis-compound CBD are expected to reach $16 billion by 2025, according to Cowen.
• Growing industrial hemp is incredibly expensive and inefficient. Lab tests aren’t always accurate.
• Retailers are receiving a flood of pitches as people try to take advantage of the so-called green rush.

Angelica LaVito | @angelicalavito

Geoffroy Van Der Hasselt | AFP | Getty Images Oils containing CBD (Cannabidiol) are seen in a shop in Paris on June 14, 2018.

It’s Hollywood’s new favorite beauty product. It’s the superfood du jour. Demand for CBD is so strong that companies are scrambling to infuse their products with it, but the CBD they’re finding isn’t all that great.

Congress legalized industrial hemp in December. With it, they also legalized hemp-derived CBD, short for cannabidiol, a cannabis compound that supposedly delivers the calming effects of marijuana without the high from THC.

Last year, retail sales of CBD consumer products in the U.S. were estimated at between $600 million and $2 billion, according to investment research firm Cowen. The bank conservatively forecasts sales to reach $16 billion by 2025, with health and wellness products leading the way and food, beverage, beauty and vapor to also play a role.

From seed to CBD

The current supply chain — from plants, to extraction, to labs — is riddled with issues. And the nascent industry is trying to work through the kinks at the same time demand is ramping up, leaving producers frustrated and consumers stuck trying to sift good products from bad ones.

“There are huge challenges to producing the industrial hemp required for meeting the demand,” said George Weiblen, a professor at the University of Minnesota who has been studying cannabis since 2002. “It’s not as simple as growing tomatoes. It’s just not. … The possibility of failure to produce quality cannabis extracts is huge.”

Decades of modern farming techniques have tamed staple crops like corn and wheat. Farmers know what to expect when they plant these crops and can follow a pretty straightforward set of guidelines when they grow them. With hemp for CBD, not so much.

More religion than science

People have been growing hemp illegally for years. Farmers have kept their operations quiet and developed their own techniques that are all a little different, said Christian Cypher, a senior vice president at Pyxus International who is leading the agriculture company’s cannabis work.

“Growing hemp has been more religion than science,” he said.

Most hemp farmers are growing the plant like a tomato, a process that’s expensive and intensive, said David Williams, an agronomist at the University of Kentucky who studies hemp. This model works for marijuana because you want the flower to look and smell nice. For hemp that will be used to extract CBD, this system is incredibly expensive and unnecessary since you only care about what’s inside the flower, Williams said.

“If the molecule is of interest and becomes broadly distributed, it will need to be far more efficient than what we have today,” he said.

Incredibly expensive

Industrial hemp produces such small amounts of CBD that growing it and harvesting it to extract the molecule is incredibly expensive. One Canadian certified industrial hemp strain produced an average of 0.6 percent CBD and 0.03 percent THC, according to a study Weiblen conducted.

Arcadia Biosciences, a company that has bred wheat to be more fibrous, recently entered the cannabis space with the aim of growing hemp that produces more CBD and no or reliably low THC. Federal law says CBD is legal so long as it contains less than 0.3 percent THC.

“We think that’s a significant opportunity,” said Matt Plavan, chief financial officer of Arcadia and president of the new cannabis-focused unit, Arcadia Specialty Genomics.

A ‘green rush’

Farmers won’t find out how much THC their plants produce until they’re harvested, dried and the CBD is extracted. During this process, the CBD becomes concentrated and the THC gets dragged along with it, Weiblen said, possibly to the point where the amount of THC exceeds the legal limit.

With CBD coming into vogue, some are latching onto the trend and cutting corners along the way.

Numerous studies, including from federal regulators, have found a slew of products don’t contain the amount of CBD they say they do.

There aren’t any federal laws requiring companies to test CBD, whether it goes into beauty or food products. Some farmers or manufacturers send their extracts in anyway, and they’re learning that lab tests are working through a similar learning curve as the rest of the supply chain.

Vastly different results

Chris Padulo, a farmer in Vermont who started growing hemp last year, sent samples to four different labs and got “vastly different results” from each. One lab said the plant he sent in contained 8 percent CBD. Another one said it contained 16 percent. The two others said it landed somewhere in the middle.

“I figured science is science,” he said. “There are no consistencies.”

Retailers say they’re constantly receiving pitches from people asking to put their products on shelves. Chris Burton, retail partner manager at online CBD store HelloMD, grills brands on where their hemp is grown, how the CBD is extracted, where their lab tests are and more.

Wild West

“Some say their CBD is the best possible and when you ask how they know they can’t answer questions,” Burton said.

Consumers shopping for CBD will find a slew of terms: isolate, full spectrum, water soluble and more, with each claiming to be better than the other. Brands are trying to differentiate themselves and prove their products are legit, especially as they introduce people to an entirely new category.

Burton says this “green rush” worries him that people seeing dollar signs are moving as fast they can to brings products to market.

“It’s really just the wild west out there,” he said.

Source: https://www.cnbc.com/2019/03/23/cbd-is-booming-but-us-farmers-struggle-to-keep-up-with-demand.html